In silico insights into design of novel VEGFR-2 inhibitors: SMILES-based QSAR modelling, and docking studies on substituted benzo-fused heteronuclear derivatives

This study concludes the development of a best fit QSAR model which can assist the design of new anticancer agents targeting VEGFR-2.PMID:38591137 | DOI:10.1080/1062936X.2024.2332203
Source: SAR and QSAR in Environmental Research - Category: Environmental Health Authors: Source Type: research